Keyvantage Wealth’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
5,852
+289
+5% +$64.6K 0.55% 29
2025
Q4
$952K Buy
5,563
+37
+0.7% +$5.75K 0.41% 38
2025
Q3
$740K Sell
5,526
-435
-7% -$46.1K 0.31% 45
2025
Q2
$580K Sell
5,961
-589
-9% -$46.7K 0.26% 54
2025
Q1
$476K Sell
6,550
-414
-6% -$32.6K 0.23% 60
2024
Q4
$503K Buy
+6,964
New +$528K 0.36% 51

Other funds holding LRCX

Keyvantage Wealth's LRCX Position: Q1 2026 in Review

Keyvantage Wealth increased its Lam Research (LRCX) stake by 5.2% in Q1 2026, buying an estimated $64.6K and bringing the position to 5,852 shares worth $1.25M. The position accounts for 0.55% of the portfolio, ranked #29.

Keyvantage Wealth first reported a position in LRCX in Q4 2024 and has held it in 6 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Keyvantage Wealth held 5,852 shares of Lam Research worth $1.25M as of Q1 2026.
  • Keyvantage Wealth bought 289 Lam Research shares in Q1 2026, an estimated $64.6K.
  • Lam Research made up 0.55% of Keyvantage Wealth's portfolio in Q1 2026, its #29 holding.
  • Keyvantage Wealth first reported a position in Lam Research in Q4 2024 and has held it in 6 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.